Clinical use of the somatostatin analog SMS 201–995 in endocrinology
- 1 November 1988
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 11 (10) , 737-740
- https://doi.org/10.1007/bf03350937
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A guide to the clinical use of the somatostatin analogue SMS 201-995 (Sandostatin)Acta Endocrinologica, 1987
- Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin AnalogueNew England Journal of Medicine, 1987
- Visualization of Somatostatin Receptors and Correlation with Immunoreactive Growth Hormone and Prolactin in Human Pituitary Adenomas: Evidence for Different Tumor SubclassesJournal of Clinical Endocrinology & Metabolism, 1987
- Medical Treatment of Acromegaly with SMS 201-995, a Somatostatin Analog: A Comparison with Bromocriptine*Journal of Clinical Endocrinology & Metabolism, 1987
- SOMATOSTATIN RECEPTORS IN HUMAN ENDOCRINE TUMORS1987
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Hyperthyroidism due to non-tumoural inappropriate TSH secretionActa Endocrinologica, 1986
- SomatostatinNew England Journal of Medicine, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982